PALO ALTO, California, April 14 /PRNewswire/ --

- FMS presents 'the Colossus' NexentaStor based solution with industry leading storage density

Nexenta Systems, Inc., developer of NexentaStor(TM), the leading enterprise class storage management software taking an open source approach to market, is pleased to announce that Enterprise Certified partner FMS is presenting this week at the Intel Solutions Summit, April 14-16 in Rome, Italy. The Intel Solution Summit is Intel's invitation only summit for Intel Premier Partners.

CALGARY, Canada, April 14 /PRNewswire/ -- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) has completed patient enrolment in the dose escalation portion of its U.K. clinical trial to evaluate the anti-tumour effects of systemic administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with advanced cancers including head and neck, melanoma, lung and ovarian.

"The preliminary results from this combination trial are very encouraging," said Dr. Brad Thompson, President and CEO of Oncolytics. "This study was the first to begin examining the use of REOLYSIN(R) with drug combinations that are used in first or second line therapy."

"The placenta is this amazing, complex structure and it's unique to mammals, but we've had no idea what its evolutionary origins are," says Julie Baker, PhD, assistant professor of genetics at Stanford Univeristy and senior author of a study in Genome Research which discusses its evolution.

The placenta is the mother's intricate lifeline to her unborn baby, delivering oxygen and nutrients critical to the baby's health. New evidence suggests the placenta of humans and other mammals evolved from the much simpler tissue that attached to the inside of eggshells and enabled the embryos of our distant ancestors, the birds and reptiles, to get oxygen.

INGELHEIM, Germany, April 14 /PRNewswire/ --

- For Medical Media, Outside the US Only

Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member states. It will be launched in Germany and Denmark in the coming weeks, followed soon by Ireland, the United Kingdom and the rest of EU, and when approved also in other countries around the world.

LONDON, April 14 /PRNewswire/ -- Today the Committee representing 12,000 Unite members working in the NHS as ancillary and ambulance staff, made the decision that in consulting with members on the government's 7.99% three year pay deal, it will recommend its members to reject the pay offer.

The Unite officer representing those NHS workers, Peter Allenson, said:

"This three year pay deal is not sufficient for us to be able to recommend acceptance to our members.

"We have reservations that the re-negotiation clause, which should come into effect in situations of rising inflation, is not strong enough and that in a climate of economic insecurity, it is not at a level sufficient to meet our members' needs."

WAALWIJK, The Netherlands, April 14 /PRNewswire/ -- Industrial Automation Integrators (IAI) B.V. in Veldhoven, a subsidiary of DOCDATA N.V. in Waalwijk, will supply a SheetMaster Flex system and a WebMaster Flex system to the Government of South Africa (Government Printing Works), to enhance the security of documents.

These systems are especially designed to process documents other than banknotes, passports and ID-cards for which IAI offers dedicated systems. Because of the huge variety in such documents worldwide, the systems need to be very flexible in order to meet the requirements of a large portion of these documents.

LONDON, April 14 /PRNewswire/ --

- ATTN: Yorkshire Editors

A Group of people with multiple sclerosis (MS) in Yorkshire are being denied access to a vital drug that has been proved to be the most effective treatment for their condition.

Mid Yorkshire Hospitals NHS Trust has failed to provide people living with a rapidly evolving and severe form of MS access to Tysabri despite being legally required to do so by the Government's drugs watchdog.

MS is the most common disabling and incurable neurological disorder affecting the central nervous system in young adults.

Succession is one of the first things that students learn about in ecology. Each intervening stage modifies the environment in such a way that lays the groundwork for the next stage, while making the environment less hospitable to its own offspring. Only the final stage is self-perpetuating and stable.

Frederic Clements, one of the pioneers of community ecology, saw ecological succession as an ontogenic process in which the community - a superorganism - developed into its final, mature form. The orderly progression from bare ground to mature forest is orderly, progressive…and very Victorian.

Each copy of the human genome consists of about 3,200,000,000 base pairs, and includes about 500,000 repeats of the LINE-1 transposable element (a LINE) and twice as many copies of Alu (a SINE), as compared to around 20,000 protein-coding genes.

Whereas protein-coding regions represent about 1.5% of the genome, about half is made up LINE-1, Alu, and other transposable element sequences. These begin as parasites, and some continue to behave as detrimental mutagens implicated in disease. However, most of those in the human genome are no longer mobile, and it is possible that many of these persist as commensal freeloaders.

Finally, it has long been expected that a significant subset of non-coding elements would be co-opted by the host and take on functional roles at the organism level, and there is increasing evidence to support this. A notable fraction of the non-genic portion of human DNA is undoubtedly involved in regulation, chromosomal function, and other important processes, but based on what we know about non-coding DNA sequences, it remains a reasonable default assumption -- though one that should continue to be tested empirically -- that much or perhaps most of it is not functional at the organism level.

This does not mean that a search for the functional segments is futile or irrelevant -- far from it, as many non-genic regions are critical for normal genomic operation and some have played an important role in many evolutionary transitions. It simply means that one must not extrapolate without warrant from discoveries involving a small fraction of sequences to the genome as a whole.

BAD HOMBURG, Germany, April 14 /PRNewswire/ --

- Campaign to Improve Treatment of Children With Diabetes

Each year, more and more children and adolescents all over the world are diagnosed with type 1 diabetes. The overall annual increase is estimated at around 3%(1). However, even in countries with highly developed health care systems, the care received by young people with diabetes is not always optimal. This is what SWEET intends to change: SWEET is the first project aimed at improving the diagnosis and care of children and adolescents with diabetes in Europe in order to prevent costly and debilitating secondary disorders. The initiative, which is subsidised by the EU, was kick-started on April 9th in Bad Homburg, Germany.